P140017S009

None

FDA Premarket Approval P140017 S009

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP140017S009
Classification NameNone
Applicant
PMAP140017
SupplementS009

Supplemental Filings

Supplement NumberDateSupplement Type
P140017Original Filing
S023 2022-11-16 30-day Notice
S022 2022-07-20 30-day Notice
S021 2022-02-28 30-day Notice
S020 2022-01-27 30-day Notice
S019 2021-07-29 30-day Notice
S018
S017 2019-10-01 30-day Notice
S016
S015 2019-06-20 30-day Notice
S014 2018-11-13 Normal 180 Day Track No User Fee
S013
S012 2018-10-01 30-day Notice
S011 2018-09-26 Real-time Process
S010 2017-12-01 30-day Notice
S009
S008 2017-09-11 30-day Notice
S007 2017-04-19 30-day Notice
S006 2016-11-23 Normal 180 Day Track No User Fee
S005 2016-09-01 Panel Track
S004 2016-04-25 Normal 180 Day Track
S003 2016-04-08 30-day Notice
S002 2016-03-23 30-day Notice
S001 2015-06-17 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00643169588455 P140017 000
00643169588448 P140017 000
00643169588431 P140017 000
00643169588196 P140017 000
00643169588189 P140017 000
00643169713895 P140017 004
00643169713901 P140017 004
00643169713888 P140017 004

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.